Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award No cap on assistance (unless otherwise specified) · Income Income-based eligibility; threshold not published · Copayments, coinsurance, deductibles, health insurance premiums, incidental medical expenses
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
C82.0 C82.1 C82.9 C83.0 C83.3 C83.5 C85.1 C85.9 C85.90 C91.0 C91.1 C91.10 C91.11 C92.0 C92.1 D69.3 D80.0 D80.1 D80.2 D80.3 D80.4 D80.5 D80.6 D80.7 D80.8 D80.9 D81.0 D81.1 D81.2 D81.9 D82.0 D82.1 D82.9 D83.0 D83.1 D83.2 D83.8 D83.9 L10.0 M05.79 M06.9 M30.3 M31.30 M31.31 M31.7 M32.14Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Also matches J-codes not yet in our drug library: J1100 J1566 J2930 J9033 J9311 Q5123
Run a Medicare estimate for a covered drug in about a minute. The fund's award caps against the patient share CareCost calculates.
As of June 3, 2026, the The Assistance Fund Chronic Lymphocytic Leukemia fund is OPEN and accepting applications. Verify at time of service: 855-220-1786.
No cap on assistance (unless otherwise specified). Copayments, coinsurance, deductibles, health insurance premiums, incidental medical expenses
Household income must be Income-based eligibility; threshold not published. U.S. resident.
Accepted: commercial, medicare, medicaid.